Clinical Studies

Safety Trial

  • 9 Patients
  • Pre-Nephrectomy

Outcome- No Adverse effects

  • Verve treatment 1 mo. prior to nephrectomy
  • Histopathology confirmed treatment zones
Results Safety Study 2
Results Safety Study

Efficacy Trial

  • 4 Patients
  • Resistant hypertensive min. 3 drugs

Outcome

  • Immediate drop in blood pressure
  • Systolic drop 44mmHg
1 month results

Efficacy Trial

  • 1 Patients
  • End stage renal disease- Dialysis- 5 drugs

Outcome

  • 14 mmHg systolic drop in blood pressure after removal of 3 drugs